GCIA
RNA

Gabelli & Co Investment Advisers’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-190,645
Closed -$3.58M – 181
2014
Q4 		$3.58M Buy
+190,645
New +$2.71M 0.51% 40

Gabelli & Co Investment Advisers's RNA Position: Q1 2015 in Review

Gabelli & Co Investment Advisers sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 190,645 shares — an estimated $3.58M sold.

Gabelli & Co Investment Advisers first reported a position in RNA in Q4 2014 and held it in 1 quarter. The position peaked at $3.58M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • Gabelli & Co Investment Advisers reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 190,645 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $3.58M.
  • Gabelli & Co Investment Advisers first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2014 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $3.58M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2015, filed 1 May 2015.